Clinical trials sponsored by Chinese SLE Treatment And Research Group

Phase breakdown

Conditions studied

Recruiting trials led by Chinese SLE Treatment And Research Group

• Chinese Rheumatism Biobank(CRB)
  NCT06887517 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 1 location
• Exploring Biomarkers for Therapeutic Response of Lupus Nephritis Based on Multi Omics Analysis
  NCT06167174 · Phase: Not specified · Ages: 16 Years to 60 Years · Sex: All (male and female) · 1 location
• Sirolimus in Patients With Systemic Lupus Erythematosus-Associated Immune Thrombocytopenia
  NCT07657793 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Vunakizumab for the Treatment of Mild to Moderate Systemic Lupus Erythematosus
  NCT06881290 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location

Common questions

How many trials is Chinese SLE Treatment And Research Group recruiting for?

Chinese SLE Treatment And Research Group is the lead sponsor of 4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.